TISSUE REGENIX GROUP

TRX
Delayed Quote. Delayed  - 10/28 11:00:24 am
0.3965GBX -6.71%
Prev.0.4200
Open0.4250
High0.4400
Low0.3905
Volume79 463 529
Latest news
02/04
05/2015
Chart TISSUE REGENIX GROUP PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBearishBearish
Resistance0,460,630,73
Spread/Res.-14%-37%-46%
Spread/Supp.4,2%31%28%
Support0,380,300,31
Financials
Sales 2020 12,5 M 16,2 M 16,2 M
Net income 2020 -5,10 M -6,60 M -6,60 M
Net Debt 2020 8,00 M 10,4 M 10,4 M
P/E ratio 2020 -4,25x
Yield 2020 -
Capitalization 29,8 M 39,0 M 38,6 M
EV / Sales 2020 3,03x
EV / Sales 2021 2,06x
Nbr of Employees 99
Free-Float 80,0%
Company
Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-06-10 Earnings Release

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 2
Average target price 0,90 GBX
Last Close Price 0,43 GBX
Spread / Highest target 112%
Spread / Average Target 112%
Spread / Lowest Target 112%